Work

Efficacy Analysis of Gefitinib +/- Ficlatuzumab in Serum Proteomic Based Subgroups of Patients with Previously Untreated Lung Adenocarcinoma

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu326.39

Authors: T.S.K. Mok, E. Tan, S.L. Greater, G. Chang, J.C. Yang, J. Gyuris, M. Han, P. Komarnitsky, F. Payumo, G. Pestano, J. Roder, D. Spinella, Z. Weng, K. Park

Institutions: Chinese University of Hong Kong, Prince of Wales Hospital, National Cancer Centre Singapore, Prince of Songkla University, Taichung Veterans General Hospital, National Taiwan University Hospital, AVEO Oncology (United States), Samsung Medical Center, Sungkyunkwan University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2342112786

FWCI: 1.07

Cites: 1

Cited by: 4

Related to: 10